ArticleJournal of the Chinese Medical Association : JCMA2023
Risk analysis of subsequent therapies after first-line chemotherapy in advanced testicular cancer patients.
Tsung-Han Yen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.